Between 1970 and 1990, of 1287 patients undergoing resection for prima
ry lung cancer, we considered 55 (4.3 %) to have a second primary lung
cancer, being synchronous in 15 cases (1.2 %) and metachronous in 40
(3.1 %). Two patients had a third primary lung cancer. The 15 patients
with synchronous cancers were all treated surgically: ten underwent a
two-stage procedure and 5 patients a one-stage. In 6 patients the can
cers were located bilaterally and in 4 patients both synchronous cance
rs had a different histology. There were 3 postoperative deaths (20 %)
. The 3- and 5-year actuarial survival rates were 26 % and 15 %. Of th
e 40 patients with metachronous cancers the mean interval between trea
tment of their first and second cancer was 5 years and 11 months. It w
as longer for the 21 patients having a contralateral second localizati
on (7 years) than for those having an ipsilateral localization (4 year
s). There was no dependence of the intervals on whether or not the sec
ond cancer had the same histology as the first cancer. In 7 patients t
he second cancer was treated by chemo- and/or radiotherapie and in 33
patients by surgery. There were 5 postoperative deaths in this group (
15.2 %). The 3- and 5-year actuarial survival rates were 33 % and 18 %
. For 25 patients with a stage I or II second cancer these rates were
42 % and 27 %; all 8 patients with a stage III second cancer died with
in 14 months. Survival was positively affected by: histological type d
iffering between both cancers, an interval of more than 3 years, a bil
ateral localization, and a stage I or II second cancer. In conclusion,
a close follow-up including a regular chest radiograph of operated lu
ng-cancer patients is necessary and in case of a new primary lung canc
er precise clinical staging; an aggressive surgical approach is indica
ted in Stage I and II second cancers.